Eastgate Biotech Corp. (ETBI)
OTCMKTS · Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
At close: Oct 12, 2026
Eastgate Biotech Revenue
Eastgate Biotech had revenue of $23.14K in the quarter ending September 30, 2017. This brings the company's revenue in the last twelve months to $137.64K, up 45,325.08% year-over-year. That makes Eastgate Biotech the 45,768th largest company in the world by revenue and 6,713th in the United States.
Revenue (ttm)
137.64K
Revenue Growth
+45,325.08%
P/S Ratio
38.43
Revenue / Employee
45.88K
Employees
3
Market Cap
5.29M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 132.03K | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Adaptimmune Therapeutics | 5.92M |
| Pacific Software | 2.40M |
| OSR Health | 1.81M |
| Orgenesis | 1.04M |
| TRON Group | 1.01M |
| VitaSpring Biomedical | -1.49M |